William A. Devane

10.5k total citations · 2 hit papers
22 papers, 8.4k citations indexed

About

William A. Devane is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, William A. Devane has authored 22 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 13 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in William A. Devane's work include Cannabis and Cannabinoid Research (19 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Neuroscience and Neuropharmacology Research (7 papers). William A. Devane is often cited by papers focused on Cannabis and Cannabinoid Research (19 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Neuroscience and Neuropharmacology Research (7 papers). William A. Devane collaborates with scholars based in United States, Israel and United Kingdom. William A. Devane's co-authors include Raphael Mechoulam, Aviva Breuer, Allyn C. Howlett, Roger G. Pertwee, Asher Mandelbaum, Lesley Stevenson, Graeme Griffin, Dan Gibson, L S Melvin and M R Johnson and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Trends in Neurosciences.

In The Last Decade

William A. Devane

21 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

1992 4.5k citations William A. Devane, Aviva Breuer et al. Science profile →
Determination and characterization of a cannabinoid receptor in rat brain.

1988 1.9k citations William A. Devane, M R Johnson et al. Molecular Pharmacology profile →

Peers

Countries citing papers authored by William A. Devane

Since Specialization

Citations

This map shows the geographic impact of William A. Devane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. Devane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. Devane more than expected).

Fields of papers citing papers by William A. Devane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William A. Devane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. Devane. The network helps show where William A. Devane may publish in the future.

Co-authorship network of co-authors of William A. Devane

This figure shows the co-authorship network connecting the top 25 collaborators of William A. Devane. A scholar is included among the top collaborators of William A. Devane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William A. Devane. William A. Devane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cannabinoid receptors in GtoPdb v.2025.1 2025 ·IUPHAR/BPS Guide to Pharmacology CITE ·Mary E. Abood, Christian C. Felder, Peter J. Greasley, Miles Herkenham, Allyn C. Howlett, George Kunos, Ken Mackie, Raphael Mechoulam, Roger G. Pertwee, Maurice R. Elphick, Vincenzo Di Marzo, S P H Alexander, Francis Barth, Tom I. Bonner, Heather B. Bradshaw, Guy A. Cabral, Pierre Casellas, Ben Cravatt, William A. Devane, Ruth A. Ross	0
2	Cannabinoid receptors in GtoPdb v.2023.1 2023 ·IUPHAR/BPS Guide to Pharmacology CITE ·Mary E. Abood, S P H Alexander, Francis Barth, Tom I. Bonner, Heather B. Bradshaw, Guy A. Cabral, Pierre Casellas, Ben Cravatt, William A. Devane, Vincenzo Di Marzo, Maurice R. Elphick, Christian C. Felder, Peter J. Greasley, Miles Herkenham, Allyn C. Howlett, George Kunos, Ken Mackie, Raphael Mechoulam, Roger G. Pertwee, Ruth A. Ross	3
3	Cannabinoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database 2019 ·IUPHAR/BPS Guide to Pharmacology CITE ·Mary E. Abood, S P H Alexander, Francis Barth, Tom I. Bonner, Heather B. Bradshaw, Guy A. Cabral, Pierre Casellas, Ben Cravatt, William A. Devane, Vincenzo Di Marzo, Maurice R. Elphick, Christian C. Felder, Peter J. Greasley, Miles Herkenham, Allyn C. Howlett, George Kunos, Ken Mackie, Raphael Mechoulam, Roger G. Pertwee, Ruth A. Ross	12
4	Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs 1998 ·European Journal of Pharmacology ·Peter W. Stengel, Marian K. Rippy, Sandra L. Cockerham, William A. Devane, Steven A. Silbaugh	11
5	The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine 1997 ·Neuroscience Letters ·Gladys Arreaza, William A. Devane, Romelda Omeir, (unknown), Jeffrey S. Kunz, B.F. Cravatt, Dale G. Deutsch	65
6	Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. 1995 ·Molecular Pharmacology ·Josef Priller, Eileen M. Briley, (unknown), William A. Devane, Ken Mackie, Christian C. Felder	54
7	Long-term synaptic transformation of hippocampal CA1 gamma-aminobutyric acid synapses and the effect of anandamide. 1995 ·Proceedings of the National Academy of Sciences ·Carlos Collin, William A. Devane, Dennis Dahl, (unknown), J Axelrod, D L Alkon	38
8	New dawn of cannabinoid pharmacology 1994 ·Trends in Pharmacological Sciences ·William A. Devane	39
9	Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents 1993 ·Pharmacology Biochemistry and Behavior ·Jacqueline N. Crawley, Rebecca L. Corwin, (unknown), Christian C. Felder, William A. Devane, Julius Axelrod	197
10	Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. 1993 ·Proceedings of the National Academy of Sciences ·Christian C. Felder, Eileen M. Briley, J Axelrod, James T. Simpson, Ken Mackie, William A. Devane	404
11	A novel probe for the cannabinoid receptor 1992 ·Journal of Medicinal Chemistry ·William A. Devane, Aviva Breuer, Tzviel Sheskin, (unknown), Moris S. Eisen, Raphael Mechoulam	144
12	Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities 1992 ·Journal of Medicinal Chemistry ·Sumner Burstein, Charlene A. Audette, Aviva Breuer, William A. Devane, (unknown), Sharon A. Doyle, Raphael Mechoulam	80
13	Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor breakdown → 1992 ·Science ·William A. Devane, (unknown), Aviva Breuer, Roger G. Pertwee, Lesley Stevenson, Graeme Griffin, Dan Gibson, Asher Mandelbaum, (unknown), Raphael Mechoulam	4492
14	A random walk through a cannabis field 1991 ·Pharmacology Biochemistry and Behavior ·Raphael Mechoulam, William A. Devane, Aviva Breuer, (unknown)	24
15	Nonpsychotropic synthetic cannabinoids as therapeutic agents. 1991 ·PubMed ·Raphael Mechoulam, Aviva Breuer, J. J. Feigenbaum, William A. Devane	7
16	Cannabinoid Receptors and Modulation of Cyclic AMP Accumulation in the Rat Brain 1990 ·Journal of Neurochemistry ·Michelle Bidaut‐Russell, William A. Devane, Allyn C. Howlett	177
17	The cannabinoid receptor: biochemical, anatomical and behavioral characterization 1990 ·Trends in Neurosciences ·Allyn C. Howlett, Michelle Bidaut‐Russell, William A. Devane, Lawrence S. Melvin, M. Ross Johnson, Miles Herkenham	258
18	Structural studies leading to the discovery of a cannabinoid binding site. 1988 ·PubMed ·M. Ross Johnson, William A. Devane, Allyn C. Howlett, L S Melvin, George M. Milne	5
19	Determination and characterization of a cannabinoid receptor in rat brain. breakdown → 1988 ·Molecular Pharmacology ·William A. Devane, (unknown), M R Johnson, L S Melvin, Allyn C. Howlett	1877
20	An Assessment of the Role of Opioid Receptors in the Response to Cannabimimetic Drugs 1986 ·Journal of Neurochemistry ·William A. Devane, James Spain, Carmine Coscia, Allyn C. Howlett	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact